SCHEMBL282936

SCHEMBL282936

C[C]1CC(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9157198 0.85
SCHEMBL23234604 0.75
SCHEMBL9553050 0.75
SCHEMBL446772 0.72
SCHEMBL1402674 0.68
SCHEMBL3139956 0.68
SCHEMBL1178726 0.66
SCHEMBL7156116 0.65 ACHE (0.40)
SCHEMBL17874213 0.64
SCHEMBL21827213 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113423745-B Method for producing polymer having compatibility with biological material 日产化学株式会社 2024-01-09 CN claimed
US-10295907-B2 Resist underlayer film-forming composition for lithography containing polymer having acrylamide structure and acrylic acid ester structure NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2019-05-21 US claimed
CN-102311381-A Method for synthesizing alpha ethyl ester derivative CHONGQING HUABANG SHENGKAI PHARMACEUTICAL CO LTD 2012-01-11 CN claimed
EP-0239357-B1 PROCESS FOR PREPARING MONOSODIUM PHOSPHOENOLPYRUVATE AND USE OF THE SAME AS VISCERAL FUNCTION IMPROVER UBE INDUSTRIES, LTD. (JP) 1991-10-16 EP claimed
US-4874882-A HYDROLYSIS OF MONOSODIUM MONOSUBSTITUTED PHOSPHOENOLPYRUVATE UBE INDUSTRIES, LTD. (JP) 1989-10-17 US claimed
EP-0239357-A2 Process for preparing monosodium phosphoenolpyruvate and use of the same as visceral function improver UBE INDUSTRIES, LTD. (JP) 1987-09-30 EP claimed
US-12044968-B2 Protective film-forming composition having acetal structure and amide structure NISSAN CHEMICAL CORPORATION (JP) 2024-07-23 US disclosed
EP-4401115-A1 METHOD FOR CLEANING SEMICONDUCTOR SUBSTRATE, METHOD FOR MANUFACTURING PROCESSED SEMICONDUCTOR SUBSTRATE, AND COMPOSITION FOR EXFOLIATION AND DISSOLUTION Nissan Chemical Corporation (JP) 2024-07-17 EP disclosed
CN-118355328-A Composition for forming resist underlayer film comprising polymer containing polycyclic aromatic group 日产化学株式会社 2024-07-16 CN disclosed
CN-118339515-A Composition for forming resist underlayer film having hydroxycinnamic acid derivative 日产化学株式会社 2024-07-12 CN disclosed
CN-118339251-A Release agent, adhesive composition, laminate, and method for producing semiconductor substrate 日产化学株式会社 2024-07-12 CN disclosed
US-20240231230-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM NISSAN CHEMICAL CORPORATION (JP) 2024-07-11 US disclosed
EP-4398285-A1 ADHESIVE COMPOSITION, MULTILAYER BODY, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2024-07-10 EP disclosed
WO-2004024094-A2 METHODS AND COMPOSITONS FOR THE USE OF D-MALIC ACID TO DECREASE SERUM TRIGLYCERIDE, CHOLESTEROL, AND LIPOPROTEIN LEVELS SAMFORD UNIVERSITY (US) 2004-03-25 WO disclosed
US-20030162811-A1 Carbinols for the treatment of neuropathic dysfunction ENDO PHARMACEUTICALS INC. 2003-08-28 US disclosed
WO-2003032910-A2 CARBINOLS FOR THE TREATMENT OF NEUROPATHIC DYSFUNCTION ENDO PHARMACEUTICALS INC. (US) 2003-04-24 WO disclosed
EP-1289944-A2 THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 Atherogenics, Inc. (US) 2003-03-12 EP disclosed
US-20020016300-A1 Thioketals and thioethers for inhibiting the expression of VCAM-1 CRABTREE ACQUISITION CO, LLC 2002-02-07 US disclosed
WO-2001070757-A2 THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 ATHEROGENICS, INC. (US) 2001-09-27 WO disclosed
US-4874882-A HYDROLYSIS OF MONOSODIUM MONOSUBSTITUTED PHOSPHOENOLPYRUVATE UBE INDUSTRIES, LTD. (JP) 1989-10-17 US disclosed